Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>ABSTRACT</jats:title> <jats:p>Human immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrospective or cross-sectional. We evaluated the association between HIV-1-specific gamma interferon (IFN-γ) release from the cells of infants of 1 to 3 months of age and peak viral loads and mortality in the first year of life among 61 Kenyan HIV-1-infected infants. At 1 month, responses were detected in 7/12 (58%) and 6/21 (29%) of infants infected in utero and peripartum, respectively (<jats:italic>P</jats:italic> = 0.09), and in ∼50% of infants thereafter. Peaks of HIV-specific spot-forming units (SFU) increased significantly with age in all infants, from 251/10<jats:sup>6</jats:sup> peripheral blood mononuclear cells (PBMC) at 1 month of age to 501/10<jats:sup>6</jats:sup> PBMC at 12 months of age (<jats:italic>P</jats:italic> = 0.03), although when limited to infants who survived to 1 year, the increase in peak HIV-specific SFU was no longer significant (<jats:italic>P</jats:italic> = 0.18). Over the first year of life, infants with IFN-γ responses at 1 month had peak plasma viral loads, rates of decline of viral load, and mortality risk similar to those of infants who lacked responses at 1 month. The strength and breadth of IFN-γ responses at 1 month were not significantly associated with viral containment or mortality. These results suggest that, in contrast to HIV-1-infected adults, in whom strong cytotoxic T lymphocyte responses in primary infection are associated with reductions in viremia, HIV-1-infected neonates generate HIV-1-specific CD8<jats:sup>+</jats:sup>-T-cell responses early in life that are not clearly associated with improved clinical outcomes.</jats:p>

Original publication

DOI

10.1128/jvi.79.13.8121-8130.2005

Type

Journal article

Journal

Journal of Virology

Publisher

American Society for Microbiology

Publication Date

01/07/2005

Volume

79

Pages

8121 - 8130